169 related articles for article (PubMed ID: 30213303)
1. [New perspectives for the diagnosis and prognosis of Graves' disease].
Tatulashvili S; Baudry C; Sadoul JL; Bihan H
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S31-S39. PubMed ID: 30213303
[TBL] [Abstract][Full Text] [Related]
2. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
3. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Graves' disease: the lost concept.
Sibarani RP
Acta Med Indones; 2009 Jan; 41(1):37-40. PubMed ID: 19258680
[TBL] [Abstract][Full Text] [Related]
5. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
Hoang TD; Mai VQ; Clyde PW; Shakir MK
Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
[TBL] [Abstract][Full Text] [Related]
7. The etiology of autoimmune thyroid disease: a story of genes and environment.
Tomer Y; Huber A
J Autoimmun; 2009; 32(3-4):231-9. PubMed ID: 19307103
[TBL] [Abstract][Full Text] [Related]
8. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.
Jacobson EM; Tomer Y
J Autoimmun; 2007; 28(2-3):85-98. PubMed ID: 17369021
[TBL] [Abstract][Full Text] [Related]
9. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
10. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers in diagnosis and prediction of relapse in Graves' disease.
Badenhoop K; Donner H; Braun J; Siegmund T; Rau H; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():98-100. PubMed ID: 8981012
[TBL] [Abstract][Full Text] [Related]
12. [Genetics of thyroid autoimmunity - update and clinical relevance].
Dultz G; Dittmar M; Kahaly GJ
Med Klin (Munich); 2009 Mar; 104(3):210-9. PubMed ID: 19337711
[TBL] [Abstract][Full Text] [Related]
13. The role of genetics in Graves' disease and thyroid orbitopathy.
Kim N; Hatton MP
Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
[TBL] [Abstract][Full Text] [Related]
14. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease.
de Roux N; Shields DC; Misrahi M; Ratanachaiyavong S; McGregor AM; Milgrom E
J Clin Endocrinol Metab; 1996 Oct; 81(10):3483-6. PubMed ID: 8855789
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease.
Watson PF; French A; Pickerill AP; McIntosh RS; Weetman AP
J Clin Endocrinol Metab; 1995 Mar; 80(3):1032-5. PubMed ID: 7883818
[TBL] [Abstract][Full Text] [Related]
17. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
[TBL] [Abstract][Full Text] [Related]
18. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
Yarman S; Oguz F; Carin M
Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
[TBL] [Abstract][Full Text] [Related]
20. Etiopathogenesis of Graves' disease.
Karasek M; Lewinski A
Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
